Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Dihydro-.alpha.-ergocryptine mesylate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    PharmaCompass
    $ API Ref.Price (USD/KG) : 81Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Teva Czech Industries s.r.o

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    Dihydro-.alpha.-ergocryptine mesylate Manufacturers

    A Dihydro-.alpha.-ergocryptine mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydro-.alpha.-ergocryptine mesylate, including repackagers and relabelers. The FDA regulates Dihydro-.alpha.-ergocryptine mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydro-.alpha.-ergocryptine mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Dihydro-.alpha.-ergocryptine mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    Dihydro-.alpha.-ergocryptine mesylate Suppliers

    A Dihydro-.alpha.-ergocryptine mesylate supplier is an individual or a company that provides Dihydro-.alpha.-ergocryptine mesylate active pharmaceutical ingredient (API) or Dihydro-.alpha.-ergocryptine mesylate finished formulations upon request. The Dihydro-.alpha.-ergocryptine mesylate suppliers may include Dihydro-.alpha.-ergocryptine mesylate API manufacturers, exporters, distributors and traders.

    click here to find a list of Dihydro-.alpha.-ergocryptine mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    Dihydro-.alpha.-ergocryptine mesylate NDC

    National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dihydro-.alpha.-ergocryptine mesylate as an active pharmaceutical ingredient (API).

    Finished drug products

    The FDA updates the NDC directory daily. The NDC numbers for Dihydro-.alpha.-ergocryptine mesylate API and other APIs are published in this directory by the FDA.

    Unfinished drugs

    The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

    Pharmaceutical companies that manufacture Dihydro-.alpha.-ergocryptine mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

    Compounded drug products

    The NDC directory also contains data on finished compounded human drug products that contain Dihydro-.alpha.-ergocryptine mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dihydro-.alpha.-ergocryptine mesylate NDC to their finished compounded human drug products, they may choose to do so.

    click here to find a list of Dihydro-.alpha.-ergocryptine mesylate suppliers with NDC on PharmaCompass.

    Dihydro-.alpha.-ergocryptine mesylate Manufacturers | Traders | Suppliers

    Dihydro-.alpha.-ergocryptine mesylate Manufacturers, Traders, Suppliers 1
    13

    We have 1 companies offering Dihydro-.alpha.-ergocryptine mesylate

    Get in contact with the supplier of your choice:

    1. Teva Pharmaceutical Industries
    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.